Cargando…
Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease (COVID-19), spreading from Wuhan to worldwide has been emerged since December 2019. Although scientists and researchers have been racing to develop specific therapeutic agents or vaccines against SARS-CoV-...
Autores principales: | Yılmaz, Soner, Ertuğrul Örüç, Nigar, Özcebe, Osman İlhami, Azap, Alpay, Çetin, Ahmet Türker, Yenicesu, İdil, Öztürk, Abdullah, Gündüz, Mehmet, Tekin, Ahmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271837/ https://www.ncbi.nlm.nih.gov/pubmed/32593519 http://dx.doi.org/10.1016/j.transci.2020.102846 |
Ejemplares similares
-
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis
por: Çınar, Olgu Erkin, et al.
Publicado: (2020) -
Iron-Refractory Iron Deficiency Anemia
por: Yılmaz Keskin, Ebru, et al.
Publicado: (2015) -
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia
por: Erkurt, Mehmet Ali, et al.
Publicado: (2020) -
Heart transplant recipient survivor from COVID-19: The first case of Turkey
por: Çınar, Güle, et al.
Publicado: (2020) -
Considerations in Surgical Convalescence
por: Cole, H. P.
Publicado: (1910)